Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEvommune Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.94 | -$0.62 | -$0.81 |
| Q2 2026 | 7 | -$0.74 | -$0.61 | -$0.66 |
| Q3 2026 | 8 | -$1.03 | -$0.69 | -$0.84 |
| Q4 2026 | 8 | -$1.12 | -$0.70 | -$0.90 |
| Q1 2027 | 3 | -$0.98 | -$0.98 | -$0.98 |
| Q2 2027 | 4 | -$1.01 | -$1.01 | -$1.01 |
| Q3 2027 | 3 | -$1.05 | -$1.05 | -$1.05 |
| Q4 2027 | 4 | -$1.10 | -$1.10 | -$1.10 |
| Q1 2028 | 4 | -$0.86 | -$0.86 | -$0.86 |
| Q2 2028 | 5 | -$0.86 | -$0.86 | -$0.86 |
| Q3 2028 | 4 | -$0.90 | -$0.90 | -$0.90 |
| Q4 2028 | 5 | -$0.89 | -$0.89 | -$0.89 |
Evommune Inc. Earnings Date And Information
Evommune Inc. last posted its earnings results on Thursday, August 6th, 2026. The company reported $-0.89 earnings per share for the quarter, missing analysts' consensus estimates of $-0.66449 by $0.22551. The company had revenue of 0 for the quarter and had revenue of 13.00 M for the year. Evommune Inc. has generated $-2 earnings per share over the last year ($-2.18 diluted earnings per share) and currently has a price-to-earnings ratio of -2.27. Evommune Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Evommune Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | -$0.66 | -$0.89 | -0.23 | $1.33 M | $0 |
| 05/15/2026 | Q1 2026 | N/A | -$0.64 | N/A | $722.17 K | $0 |
| 03/27/2026 | Q4 2025 | N/A | -$0.90 | N/A | $0 | $0 |
| 12/15/2025 | Q3 2025 | N/A | -$0.40 | N/A | $3.33 M | $10.00 M |
| 06/29/2025 | Q2 2025 | N/A | -$0.45 | N/A | N/A | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$0.48 | N/A | N/A | $3.00 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.63 | N/A | N/A | $0 |
| 06/29/2024 | Q2 2024 | N/A | -$0.91 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.09 | N/A | N/A | $7.00 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Evommune Inc. Earnings: FAQ's
The conference call for Evommune Inc.'s latest earnings report can be listened to online.
The conference call transcript for Evommune Inc.'s latest earnings report can be read online.
Evommune Inc. (:EVMN) has a recorded annual revenue of $13.00 M.
Evommune Inc. (:EVMN) has a recorded net income of $-68,870,000.Evommune Inc. has generated $-2.18 earnings per share over the last four quarters.
Evommune Inc. (:EVMN) has a price-to-earnings ratio of -2.27 and price/earnings-to-growth ratio is 0.04.